- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive: June 2023
2023 Pharm Exec Top 50 Companies
June 10, 2023
Features
43
6
With the sales boom from COVID-19 products now in the rear-view, a resetting is underway for those in Pharm Exec’s listing of the top biopharma producers—shifting attention to new Rx roads ahead and the steady strategies needed to navigate a bumpy business terrain.
Great Leaders Listen
June 10, 2023
Executive Profile
43
6
Jag Dosanjh, president of US neuroscience and eye care for AbbVie and HBA’s 2023 honorable mentor of the year, shares what leadership qualities are most important in today’s “people industry”—and the impact more voices can make in stakeholder communication and messaging.
Measuring Pharma’s Trust Performance
June 09, 2023
Features
43
6
The core building blocks of trust must be operationalized for pharma companies to strengthen their social contract, deliver business value, and improve patients’ quality of life.
Embracing Generative AI: Why Its Disruption is Positive for Pharma
June 09, 2023
Features
43
6
The new era of generative AI is poised to impact pharma marketing and engagement in powerful and lasting ways. But amid all the technological praise, what are the key considerations brand teams must navigate?
Tapping NPs and PAs in Life Sciences Marketing
June 09, 2023
Features
43
6
Amid the shifting focus from primary care to specialty care, using data-driven tactics can create tailored campaigns and meaningful relationships with nurse practitioners and physician assistants.
The Quest to Fully Address Prescription Drug Affordability
June 09, 2023
Back Page
43
6
The Medicare Part D cap won’t solve need for financial assistance.
How Pharma Should Prepare for Looming Nursing Shortage
June 08, 2023
Column
43
6
The impact on clinical trial staffing would be particularly significant.
Could a Rates Pivot By Fed Change Biotech’s Fate?
June 07, 2023
Column
43
6
Such a scenario is one possibility as the bear market languishes on.
A Success Story for a Brand and for Women: 'Welcome to My Vagina'
June 07, 2023
Column
43
6
Creative audacity and innovation often take a backseat to rigid regulatory adherence in pharma advertising—but there are exceptions.
New EU Proposals to Regulate Pharma Duck the Difficult Questions
June 07, 2023
Column
43
6
Advancing the concept of "health competencies" remains elusive.
Pharma Trends & Trust
June 07, 2023
From the Editor
43
6
This month, we deliver deep dives into the industry's commercial output and outlook and how drugmakers are faring in their public trust mandate—two areas where respective growth pursuits can often go hand-in-hand.
ASCO: A Time to Reflect and Learn
June 07, 2023
Publisher's Note
43
6
As conference season ramps up, it's a good time to reflect on the impact advances in pharma have on patients.
Pharmaceutical Executive, June 2023 Issue (PDF)
June 05, 2023
Issue PDF
43
6
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
FDA Eyes New Strategies to Spur Gene Therapy Development
May 03, 2023
Column
43
6
Agency seeks added resources and new approaches to accelerate more of these promising treatments to the market.